Dr. Rajesh Ponugupati. (2016). EFFICACY AND SAFETY OF DUAL INTERLEUKIN-17A AND INTERLEUKIN-17F INHIBITION WITH BIMEKIZUMAB IN ACTIVE PSORIATIC ARTHRITIS: RESULTS FROM A PHASE 3 RANDOMISED CONTROLLED TRIAL. Journal of Population Therapeutics and Clinical Pharmacology, 23(2), 237-246. https://doi.org/10.53555/am143177